• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Tuesday, July 8, 2025
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Business

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

by Aashish Sehrawat
November 13, 2021
in Business, Markets, News, Popular
Reading Time: 2 mins read
0
Snap sued for misrepresenting impact of Apple privacy changes

Image: newyorklatestnews

TwitterWhatsappLinkedin
Image: newyorklatestnews

Johnson & Johnson wants to split into two entities, splitting its enormous consumer division, which includes Band-Aids, Tylenol, and the contentious baby powder, from its pharmaceutical and medical device units, according to the company’s retiring CEO.

You might also like

Oracle Offers Steep Discounts to US Government as Stock Hits New Highs

Vaibhav Taneja: The Indian-Origin Tesla CFO Chosen by Elon Musk as Treasurer for America Party

Top 10 Richest People in India July 2025: Mukesh Ambani Leads the List

The split will legally separate the company’s rapidly growing — but extremely dangerous — pharmaceutical and medical device businesses from its consumer-focused business, which includes well-known names like Neutrogena skin care products and Listerine mouthwash.

“The best path forward to ensure sustainable growth over the long term and better meet patient and consumer demands is to have our consumer business operate as a separate health care company,” CEO Alex Gorsky said in an interview with the Wall Street Journal.

Gorsky said earlier this year that he plans to retire in 2022, citing a desire to spend more time with his family as the reason. Next year, Joaquin Duato, a company veteran, will take over.

The $430 billion corporation’s consumer division has been hamstrung in recent years by expensive lawsuits alleging that its now-famous Johnson’s Baby Powder caused cancer, though Gorsky told the Journal that the claims had no bearing on the decision to split the company up.

The business unit had a run-in with controversy earlier this year when it recalled five of its Neutrogena and Aveeno spray sunscreens after tiny quantities of benzene, a cancer-causing ingredient, were discovered in some samples. A lawsuit was filed soon after.

Gorsky was tight-lipped in the Journal interview, adding that the name of the new firm, who will manage it, and how the split will be organized are all unknowns, but he did say that J&J wanted to structure the deal to minimize taxes.

On the announcement, J&J stock jumped more than 4% in premarket trade. The stock was selling at slightly over $170.25 a share at the time of writing. Since January 1, the stock has only increased by about 4%.

Pfizer and Merck both broke off their consumer operations to focus on the faster-growing pharmaceuticals market, where a single successful medicine from the research division may bring in billions of dollars in sales.

The decision also comes amid a series of large breakups of century-old corporations, signaling the end of an era of enormous multinational conglomerates, which have been out of favor on Wall Street for a long time.

General Electric revealed plans to split into three companies earlier this week, while Toshiba announced plans to split into three companies on Friday.

Tags: colgateconsumerproductsFMCGJ&Jsplit
Tweet54SendShare15
Previous Post

Snap sued for misrepresenting impact of Apple privacy changes

Next Post

Reliance Retail acquires 100% stakes in Sri Lankan lingerie brand ‘amante’

Aashish Sehrawat

Recommended For You

Oracle Offers Steep Discounts to US Government as Stock Hits New Highs

by Rounak Majumdar
July 7, 2025
0
Oracle Offers Steep Discounts to US Government as Stock Hits New Highs

Oracle has entered into a significant agreement with the US General Services Administration (GSA), offering federal agencies a 75% discount on its license-based software and substantial reductions on...

Read more

Vaibhav Taneja: The Indian-Origin Tesla CFO Chosen by Elon Musk as Treasurer for America Party

by Rounak Majumdar
July 7, 2025
0
Vaibhav Taneja: The Indian-Origin Tesla CFO Chosen by Elon Musk as Treasurer for America Party

Vaibhav Taneja’s story is a testament to the power of discipline and expertise quietly shaping global boardrooms. Born and raised in Delhi in 1977, Taneja’s academic path began...

Read more

Top 10 Richest People in India July 2025: Mukesh Ambani Leads the List

by Rounak Majumdar
July 7, 2025
0
Top 10 Richest People in India July 2025: Mukesh Ambani Leads the List

ndia continues to cement its place as an economic powerhouse, now ranking third globally in the number of billionaires, trailing only the United States and China. As of...

Read more
Next Post
A Reliance logo can be seen in Kolkata, India

Reliance Retail acquires 100% stakes in Sri Lankan lingerie brand 'amante'

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?